Effect of Combined Prescription of Linggui Zhugan Tang and Yinchenhao Tang on Nrf2/ARE Signaling Pathway in Rats with Non-alcoholic Steatohepatitis
Yi GUO,Jun-xiang LI,Tang-you MAO,Chen CHEN,Tian-hong XIE,Ya-fei HAN,Lei SHI,Xiang TAN,Hai-xiao HAN
DOI: https://doi.org/10.13422/j.cnki.syfjx.2017160108
2017-01-01
Abstract:Objective:To observe the effects of combined prescription of Linggui Zhugan Tang (LGZGT) and Yinchenhao Tang (YCHT) on Nrf2/ARE signaling pathway in rats with non-alcoholic steatohepatitis (NASH) from the perspective of oxidative stress,and investigate its mechanism for treating non-alcoholic steatohepatitis.Method:SPF grade SD rats were randomly divided into normal control group,model group,sulforaphane group (0.5 mg·kg-1),LGZGT group (3.465 g·kg-1),YCHT group (3.465 g·kg-1) and LGZGT + YCHT combination group (6.93 g·kg-1).High-fat diet was given to establish NASH models,and the treatment was given at the same time for 8 weeks.Then the serum was harvested separately to detect the levels of alanine aminotransferase (ALT),aspartate aminotransferase (AST),total cholesterol (TC),triglyceride (TG),highdensity lipoprotein (HDL-C),and low density lipoprotein (LDL-C);part liver tissues were taken for HE staining;Western blot and reverse transcription PCR were used respectively to detect the protein and mRNA expression levels of Kelch-like ECH-associated protein 1 (Keap1),nuclear factor E2-related factor 2 (Nrf2),quinone oxidoreductase-1 (NQO1),and heme oxygenase-1 (HO-1).Result:As compared with normal control group,the levels of TC,TG,HDL-C and LDL-C in blood lipid and ALT,AST levels in serum were increased;liver fat became obvious;the expression level of Keap1 in liver was decreased;and,Nrf2,NQO1,HO-1 protein and mRNA expression levels were increased in the model group (P ＜ 0.05).As compared with the model group,the levels of TC,TG,HDL-C and LDL-C in blood lipid and ALT,AST levels in serum were decreased in various treatment groups,liver pathology was also improved to some extent;and Nrf2,NQO1,HO-1 protein and mRNA expression levels were increased in treatment groups (P ＜ 0.01,P ＜ 0.05) except YCHT group.However,the levels of Keap1 didn't show obvious differences among the treatment groups.Conclusion:LGZGT and its combination formula may improve oxidative stress to prevent and treat NASH via activating Nrf2/ARE signaling pathway in the liver.